Recent clinical studies surrounding this compound, specifically the high-dose formulation branded as ZPHC, indicate a impressive benefit on weight decrease and related health illnesses . Scientists anticipate that this combined compound, targeting both GLP-1 and GIP systems, has the potential to represent a noteworthy breakthrough in the management